We are live on ! Find out more
CLB icon

Core Laboratories

194 hedge funds and large institutions have $1.05B invested in Core Laboratories in 2024 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 73 increasing their positions, 59 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

920% more call options, than puts

Call options by funds: $3.06M | Put options by funds: $300K

26% more capital invested

Capital invested by funds: $830M → $1.05B (+$218M)

24% more repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 59

6.42% more ownership

Funds ownership: 103.75%110.17% (+6.4%)

3% less first-time investments, than exits

New positions opened: 28 | Existing positions closed: 29

2% less funds holding

Funds holding: 197194 (-3)

Holders
194
Holders Change
-3
Holders Change %
-1.52%
% of All Funds
2.8%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
28
Increased
73
Reduced
59
Closed
29
Calls
$3.06M
Puts
$300K
Net Calls
+$2.76M
Net Calls Change
-$3.52M
Name Holding Trade Value Shares
Change
Change in
Stake
AI
1
Ariel Investments
Illinois
$209M -$9.44M -533,361 -5%
BlackRock
2
BlackRock
New York
$158M -$3.21M -181,328 -2%
Vanguard Group
3
Vanguard Group
Pennsylvania
$112M +$2.47M +139,423 +3%
DGI
4
Disciplined Growth Investors
Minnesota
$90.5M +$64.5M +3,644,963 +447%
EARNEST Partners
5
EARNEST Partners
Georgia
$66.7M +$3.46M +195,756 +6%
State Street
6
State Street
Massachusetts
$38.9M -$3.12M -176,288 -8%
CAM
7
Congress Asset Management
Massachusetts
$34.2M +$1.43M +80,958 +5%
Morgan Stanley
8
Morgan Stanley
New York
$21.8M +$556K +31,421 +3%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$21.2M +$1.15M +64,935 +7%
RA
10
Royce & Associates
New York
$19M -$3.15M -178,194 -16%
T. Rowe Price Investment Management
11
T. Rowe Price Investment Management
Maryland
$18.8M +$16.4M +927,497 New
Fisher Asset Management
12
Fisher Asset Management
Washington
$16.8M +$85.7K +4,844 +0.6%
Dimensional Fund Advisors
13
Dimensional Fund Advisors
Texas
$15.3M -$997K -56,361 -7%
BTW
14
Boston Trust Walden
Massachusetts
$14.8M +$168K +9,468 +1%
Charles Schwab
15
Charles Schwab
California
$12.2M -$382K -21,595 -3%
FAM
16
Fred Alger Management
New York
$11M -$5.63M -318,121 -37%
VanEck Associates
17
VanEck Associates
New York
$11M -$1.76M -99,194 -16%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$10.5M +$685K +38,726 +8%
Northern Trust
19
Northern Trust
Illinois
$10.1M -$127K -7,171 -1%
GJL
20
Gendell Jeffrey L
$9.16M +$2.21M +124,737 +38%
WI
21
Wintrust Investments
Illinois
$8.3M -$230K -13,000 -3%
Hotchkis & Wiley Capital Management
22
Hotchkis & Wiley Capital Management
California
$7.27M +$28.1K +1,590 +0.4%
Invesco
23
Invesco
Georgia
$6.51M -$1.59M -89,981 -22%
Envestnet Asset Management
24
Envestnet Asset Management
Illinois
$6.21M +$604K +34,149 +13%
Ameriprise
25
Ameriprise
Minnesota
$6.11M -$485K -27,393 -8%

CLB Hedge Fund Activity: Q2 2024 in Review

194 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q2 2024, worth a combined $1.05B — up 26% from $830M a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of CLB and 28 opened new positions — a net loss of 1 holder — while 59 trimmed existing stakes and 73 added.

The largest buyer was Disciplined Growth Investors, adding an estimated $64.5M. The largest seller was Ariel Investments, cutting an estimated $9.44M.

  • 194 institutional investors held Core Laboratories (CLB) as of Q2 2024, down from 197 in Q1 2024.
  • Funds reported $1.05B of Core Laboratories stock for Q2 2024, up 26% quarter-over-quarter.
  • 28 funds opened new Core Laboratories positions in Q2 2024 and 29 closed out, a net change of -1 holder.
  • The largest Core Laboratories buyer in Q2 2024 was Disciplined Growth Investors, an estimated $64.5M added.
  • The largest Core Laboratories seller in Q2 2024 was Ariel Investments, an estimated $9.44M sold.

Based on aggregated 13F filings for Q2 2024.